Moreover, we also detected CD56+ NK cell infiltration within tumor cores in patients with HCC recurrence (Table 2), emphasizing NK dual role in tumor immunity and immune escape (40), and validating other reports suggesting dysfunctional NK cell activity in HCC (41–44). Here, NCAM1 is linked to hepatocellular carcinoma.